Cody Browning
Psychiatry · Atlanta, GANPI 1316470495
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 216 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations.
Across 216 payments — averaging $21.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$883
- Otsuka America Pharmaceutical, Inc.$490
- Tris Pharma Inc$470
- AbbVie$375
- Johnson & Johnson$314
- Bausch Health US, LLC$267
- plus $2K from 14 others
What the payments were for
- Food & beverage$4,617100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 38 | $883 |
| Otsuka America Pharmaceutical, Inc. | 24 | $490 |
| Tris Pharma Inc | 22 | $470 |
| AbbVie | 20 | $375 |
| Johnson & Johnson | 13 | $314 |
| Bausch Health US, LLC | 13 | $267 |
| Axsome Therapeutics, Inc. | 10 | $265 |
| Lundbeck LLC | 11 | $225 |
| Noven Therapeutics, LLC | 11 | $211 |
| Supernus Pharmaceuticals, Inc. | 9 | $210 |
| Corium, LLC | 10 | $168 |
| Neurocrine Biosciences, Inc. | 7 | $147 |
| Ironshore Pharmaceuticals Inc. | 6 | $146 |
| Collegium Pharmaceutical, Inc. | 6 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $111 |
| Vanda Pharmaceuticals Inc. | 4 | $84 |
| Teva Pharmaceuticals USA, Inc. | 3 | $46 |
| Idorsia Pharmaceuticals US Inc | 2 | $38 |
| Alkermes, Inc. | 1 | $25 |
| Tempus AI, Inc | 1 | $24 |
How this compares
$4,617 in reported general payments places this provider in the 85th percentile of 900 psychiatry providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Vilazodone Hcl | 15 | $2,404 |
| Duloxetine Hcl | 18 | $181 |
| Gabapentin | 16 | $96 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Atlanta
- David PurselleAtlanta$307K
- Michael BurkeAtlanta$217K
- Bryon EvansAtlanta$211K
- Kerry ResslerAtlanta$196K
- Patricio Riva PosseAtlanta$122K
- Ray HorwitzAtlanta$64K
- Boadie DunlopAtlanta$61K
- Zohaib HaqueAtlanta$49K
- Raymond KotwickiAtlanta$44K
- Joseph BergerAtlanta$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.